SCHEMBL4300946

SCHEMBL4300946

N#Cc1cc2ccncc2c2cc(Cl)ccc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCOA3 Q9Y6Q9 1/20 0.68
DYRK1A Q13627 6/20 0.52
CDK5 Q00535 4/20 0.48
CDK5R1 Q15078 4/20 0.48
CLK1 P49759 4/20 0.48
CLK2 P49760 4/20 0.48
CLK4 Q9HAZ1 4/20 0.48
DYRK1B Q9Y463 4/20 0.48
CLK3 P49761 3/20 0.48
HIPK2 Q9H2X6 1/20 0.47
CHEK1 O14757 1/20 0.47
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
HTT P42858 2/20 0.41
CCNT1 O60563 1/20 0.40
CDK9 P50750 1/20 0.40
HASPIN Q8TF76 1/20 0.40
PTGES O14684 3/20 0.40
CYP2A6 P11509 1/20 0.40
JAK2 O60674 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4297665 0.82 NCOA3 (0.68) NCOA3DYRK1ACDK5CDK5R1CLK1
SCHEMBL13659546 0.81 NCOA3 (1.00) NCOA3DYRK1ACDK5CDK5R1CLK1
SCHEMBL13659605 0.76 NCOA3 (0.40) NCOA3DYRK1ACDK5CDK5R1CLK1
SCHEMBL4290110 0.76 CHEK1 (0.52) NCOA3DYRK1ACDK5CDK5R1CLK1
SCHEMBL4298982 0.75 CHUK (0.49) NCOA3DYRK1ACLK1HIPK2HTT
SCHEMBL4295258 0.73 KDM4E (0.41) NCOA3DYRK1AHIPK2HTTHASPIN
SCHEMBL4296237 0.73 CCNT1 (0.40) NCOA3HIPK2HTTCCNT1CDK9
SCHEMBL11495903 0.72 NCOA3 (0.54) NCOA3DYRK1ACDK5CDK5R1CLK1
SCHEMBL6121563 0.72 CHEK1 (0.51) NCOA3DYRK1AHIPK2CHEK1PTGES
SCHEMBL4294298 0.72 KDM4E (0.51) HIPK2KMT2AMEN1HTTPTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
WO-2007008502-A2 INHIBITORS OF CHECKPOINT KINASES MERCK & CO., INC. (US) 2007-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258852-A1 Inhibitors of Checkpoint Kinases CHEK1, CHEK2, CDKN1A NCOA3 858/4885DYRK1A 762/4885CDK5 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.